Redhill Biopharma Ltd. (RDHL)
Nasdaq: RDHL · Pharmaceutical Preparations · Tel Aviv, IL · filing with the SEC since 2012
Who runs Redhill Biopharma Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Ben-Asher Dror
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
6
of 10 people with a filing in the last fifteen months
Directors reporting now
4
10 people on the record since 2026
Officerssales are open-market, Oct 6, 2025 to Oct 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Raday Gilead | Chief Operating Officer | Mar 2026 | Oct 6, 2026 | 3 · $0.00 |
| Ben-Asher Dror | Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Ingber Razi | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
| Frish Adi | Chief Corp & BD Officer | Mar 2026 | Mar 18, 2026 | none |
| Goldberg Guy Joel | Chief Business Officer | Mar 2026 | Mar 18, 2026 | none |
| Scruggs Rick D | Chief Commercial Officer | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Oct 6, 2025 to Oct 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Tsimchi Ofer | director | Mar 2026 | Mar 19, 2026 | none |
| Cabilly Shmuel | director | Mar 2026 | Mar 18, 2026 | none |
| Mamluk Roni | director | Mar 2026 | Mar 18, 2026 | none |
| Reed Kenneth | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.